# Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy

> **NCT04281602** · — · UNKNOWN · sponsor: **University Hospital, Caen** · enrollment: 25 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04281602
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-18
- **Primary completion:** 2023-01-02
- **Final completion:** 2024-05-02
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04281602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04281602, "Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04281602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*